Wealthspire Advisors (Maryland)’s Kyntra Bio KYNB Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7	Closed	-$10K	–	989
2019 Q1	$10K	Buy	+7	New	+$9.49K	﹤0.01%	1530
2018 Q4	–	Hold	0	–	–	–	2470
2018 Q3	–	Sell	-11	Closed	-$17K	–	2417
2018 Q2	$17K	Hold	11	–	–	﹤0.01%	1374
2018 Q1	$13K	Hold	11	–	–	﹤0.01%	1453
2017 Q4	$13K	Hold	11	–	–	﹤0.01%	1479
2017 Q3	$15K	Hold	11	–	–	﹤0.01%	1404
2017 Q2	$9K	Hold	11	–	–	﹤0.01%	1568
2017 Q1	$7K	Hold	11	–	–	﹤0.01%	1442
2016 Q4	$6K	Hold	11	–	–	﹤0.01%	1347
2016 Q3	$6K	Hold	11	–	–	﹤0.01%	1356
2016 Q2	$4K	Hold	11	–	–	﹤0.01%	1379
2016 Q1	$6K	Hold	11	–	–	﹤0.01%	1297
2015 Q4	$8K	Buy	+11	New	+$7.3K	﹤0.01%	1247

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s KYNB Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 7 shares — an estimated $10K sold.

Wealthspire Advisors (Maryland) first reported a position in KYNB in Q4 2015 and held it in 12 quarters. The position peaked at $17K in Q2 2018. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

Wealthspire Advisors (Maryland) reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 7 Kyntra Bio shares in Q2 2019, an estimated $10K.
Wealthspire Advisors (Maryland) first reported a position in Kyntra Bio in Q4 2015 and held it in 12 quarters.
Wealthspire Advisors (Maryland)'s Kyntra Bio position peaked at $17K in Q2 2018.
190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.